Synthesis 1991; 1991(1): 59-62
DOI: 10.1055/s-1991-26380
paper
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

A Facile Method for the Side-Chain Protection of α-Methyl-β-3, 4-dihydroxyphenyl-L-alanine (αMeDopa) for Solid-Phase Peptide Synthesis

Kun-hwa Hsieh* , Margaret M. deMaine
  • *Department of Veterinary and Comparative Anatomy, Pharmacology and Physiology, Washington State University, Pullman, WA 99164, USA
Further Information

Publication History

Publication Date:
17 September 2002 (online)

Two approaches have been used to prepare N α-tert-butoxycarbonyl-α-methyl-β-3,4-dimethoxy-, or dibenzyloxyphenyl-L-alanine, N α-Boc-α-MeDopa(R)2, where R is the methyl or benzyl ether. In the first approach, α-methyl-β-3,4-dihydroxyphenyl-L-alanine (αMeDopa) is reacted with di-tert-butyl dicarbonate (Boc2O) in the presence of sodium bicarbonate under anhydrous conditions. The resultant N-protected derivative (Boc-αMeDopa) is methylated with methyl iodide/sodium carbonate, followed by reaction with methyl iodide/tetramethylammonium hydroxide, and saponification with potassium hydroxide in aqueous dioxane to give N α-tert-butoxycarbonyl-α-methyl-β-3,4-dimethoxyphenyl-L-alanine, Boc-αMeDopa(Me)2, in 30% overall yield. In the second approach, methyl ester of α-methyl-β-3,4-dihydroxyphenyl-L-alanine is prepared by the thionyl chloride/methanol procedure, followed by N-protection with di-tert-butyl dicarbonate/sodium bicarbonate, sidechain protection with benzyl chloride/tetramethylammonium hydroxide, and saponification with sodium hydroxide in aqueous dioxane to give N α-tert-butoxycarbonyl-α-methyl-β-3,4-dibenzyloxyphenyl-L-alanine, Boc-αMeDopa(CH2Ph)2, in 46% overall yield. The latter derivative has been incorporated into angiotensin II under stepwise solid-phase peptide synthesis and solution coupling conditions.

    >